Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

pDNA/cationic lipid molecule nanoparticles

Based on

1 Patents
2013 Most recent source

Composition

1

di(Z)-octadec-9-enyl 1-(4-((6-amino-2-(butylamino)-8-hydroxy-9H-purin-9-yl)methyl) phenyl)-1-oxo-2,6,11,15-tetraazaoctadecan-18-ylphosphonate

Type Single Compound
Formula C66H119N10O5P
Role raw materials
2

pBsr2 pCpGLacZh plasmid

Type Biomolecule
Formula
Role raw materials

Properties

Applications

Area Application Source

Full content is available to subscribers only

To view content please choose from the following:

Characterization

Method Source

Full content is available to subscribers only

To view content please choose from the following:

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • di(Z)-octadec-9-enyl 1-(4-((6-amino-2-(butylamino)-8-hydroxy-9H-purin-9-yl)methyl) phenyl)-1-oxo-2,6,11,15-tetraazaoctadecan-18-ylphosphonate
  • pBsr2 pCpGLacZh plasmid
Product

pDNA/cationic lipid molecule nanoparticles

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial